Cosmo, you are right. Cutting operating costs, and hopefully the commission structure, will definitely improve SCRC's profitability. Just taking the adjudication process "In House" makes that $3.5M look more like $4.0M to me. Now, let's combine these results with news about the expanded pharmacies Mr. Schneiderman spoke about several weeks ago, the Diabetes Program, PIMD's impact to the bottom line, the Physician Dispensing Program, and yes, RapiMeds. Then, 2015 will be enormous. I know we have been saying this for months, but SCRC is so close to greatness.